Kaveri Pohlman
Stock Analyst
(n/a)
# 4,617
Out of 4,623 analysts
22
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kaveri Pohlman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MGNX MacroGenics | Downgrades: Neutral | n/a | $4.14 | - | 4 | Aug 1, 2024 | |
| GMAB Genmab | Maintains: Buy | $46 → $47 | $23.53 | +99.75% | 3 | Jun 27, 2024 | |
| CGEM Cullinan Therapeutics | Maintains: Buy | $20 → $30 | $16.22 | +84.96% | 2 | Apr 17, 2024 | |
| XNCR Xencor | Maintains: Buy | $56 → $38 | $21.29 | +78.49% | 1 | Apr 16, 2024 | |
| NUVB Nuvation Bio | Upgrades: Buy | $5 | $2.27 | +120.26% | 2 | Mar 26, 2024 | |
| JANX Janux Therapeutics | Initiates: Buy | $62 | $49.55 | +25.13% | 1 | Mar 21, 2024 | |
| PYXS Pyxis Oncology | Initiates: Buy | $8 | $3.23 | +147.68% | 1 | Feb 9, 2024 | |
| EXEL Exelixis | Initiates: Buy | $27 | $26.23 | +2.94% | 1 | Dec 19, 2023 | |
| RCUS Arcus Biosciences | Reiterates: Buy | $70 | $18.37 | +281.06% | 1 | Aug 23, 2023 | |
| STTK Shattuck Labs | Initiates: Buy | $12 | $1.54 | +679.22% | 1 | Aug 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $8 | $1.15 | +595.65% | 2 | Jul 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.12 | +8,828.57% | 1 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12,320 → $4,928 | $4.76 | +103,429.41% | 2 | Feb 9, 2022 |
MacroGenics
Aug 1, 2024
Downgrades: Neutral
Price Target: n/a
Current: $4.14
Upside: -
Genmab
Jun 27, 2024
Maintains: Buy
Price Target: $46 → $47
Current: $23.53
Upside: +99.75%
Cullinan Therapeutics
Apr 17, 2024
Maintains: Buy
Price Target: $20 → $30
Current: $16.22
Upside: +84.96%
Xencor
Apr 16, 2024
Maintains: Buy
Price Target: $56 → $38
Current: $21.29
Upside: +78.49%
Nuvation Bio
Mar 26, 2024
Upgrades: Buy
Price Target: $5
Current: $2.27
Upside: +120.26%
Janux Therapeutics
Mar 21, 2024
Initiates: Buy
Price Target: $62
Current: $49.55
Upside: +25.13%
Pyxis Oncology
Feb 9, 2024
Initiates: Buy
Price Target: $8
Current: $3.23
Upside: +147.68%
Exelixis
Dec 19, 2023
Initiates: Buy
Price Target: $27
Current: $26.23
Upside: +2.94%
Arcus Biosciences
Aug 23, 2023
Reiterates: Buy
Price Target: $70
Current: $18.37
Upside: +281.06%
Shattuck Labs
Aug 31, 2022
Initiates: Buy
Price Target: $12
Current: $1.54
Upside: +679.22%
Jul 7, 2022
Maintains: Buy
Price Target: $16 → $8
Current: $1.15
Upside: +595.65%
Feb 24, 2022
Initiates: Buy
Price Target: $100
Current: $1.12
Upside: +8,828.57%
Feb 9, 2022
Maintains: Buy
Price Target: $12,320 → $4,928
Current: $4.76
Upside: +103,429.41%